Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.07.2021 | Case report

Epoetin-α

Development of anti-erythropoietin antibodies and lack of efficacy : case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Cai KD, et al. Successful application of roxadustat in the treatment of patients with anti-erythropoietin antibody-mediated renal anaemia: a case report and literature review. [Review]. Journal of International Medical Research 49: 1-6, No. 4, Apr 2021. Available from: URL: http://doi.org/10.1177/03000605211005984 Cai KD, et al. Successful application of roxadustat in the treatment of patients with anti-erythropoietin antibody-mediated renal anaemia: a case report and literature review. [Review]. Journal of International Medical Research 49: 1-6, No. 4, Apr 2021. Available from: URL: http://​doi.​org/​10.​1177/​0300060521100598​4
Metadaten
Titel
Epoetin-α
Development of anti-erythropoietin antibodies and lack of efficacy : case report
Publikationsdatum
01.07.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-99083-3

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

mRNA-1273

Case report

Heparin